Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

计划入组 136 人 · 首次发布于 2025 年 8 月 13 日

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

计划入组 105 人 · 首次发布于 2026 年 6 月 12 日

A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV

计划入组 57 人 · 首次发布于 2023 年 9 月 13 日

N332-GT5 gp140

N332-GT5 gp140 adjuvanted With SMNP

Single-Dose HIV Vaccine Candidate Induces Neutralizing Antibodies in Nonhuman Primates

Long-Acting Anti-TSLP Antibody HBM9378/WIN378 Enters Global Phase 2 Trial for Asthma Treatment

Kelun-Biotech and Windward Bio Report Positive Phase 2 Interim Data for Twice-Yearly Asthma Antibody SKB378/WIN378